Sherry Yang
Thomas Jefferson University(US)Thomas Jefferson University Hospital(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Hidradenitis Suppurativa and Treatments, Breast Cancer Treatment Studies, Colorectal Cancer Treatments and Studies, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes(2007)166 cited
- → Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors(2006)155 cited
- → Complications in the first year following cataract surgery with and without IOL in infants and older children(2002)113 cited
- → Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer(2008)94 cited
- → Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors(2015)68 cited
- → Foundation Models for Decision Making: Problems, Methods, and Opportunities(2023)50 cited